Prospera Financial Services Inc Talaris Therapeutics, Inc. Transaction History

Prospera Financial Services Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$1.09 - $2.09 $23,499 - $45,058	-21,559 Reduced 60.67%	13,973 $26,000
Q4 2022 Feb 08, 2023	BUY	$0.94 - $1.64 $21,225 - $37,031	22,580 Added 174.34%	35,532 $36,000
Q3 2022 Oct 27, 2022	BUY	$2.3 - $5.03 $29,789 - $65,148	12,952 New	12,952 $34,000
Q2 2022 Aug 08, 2022	SELL	$4.51 - $9.85 $22,798 - $49,791	-5,055 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$6.89 - $16.56 $34,828 - $83,710	5,055 New	5,055 $50,000

75.7K

Ticker TALS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,995,900
Market Cap $109M
Description
Talaris Therapeutics, Inc. operates as a late-clinical stage cell therapy company in the United States. The company engages in developing a method of allogeneic hematopoietic stem cell transplantation to transform the standard of care in solid organ transplantation and severe autoimmune diseases, as well as severe non-malignant blood, immune, an...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.